ABCA3 and LZTFL1 Polymorphisms and Risk of COVID-19 in the Czech Population.
Journal
Physiological research
ISSN: 1802-9973
Titre abrégé: Physiol Res
Pays: Czech Republic
ID NLM: 9112413
Informations de publication
Date de publication:
31 Aug 2023
31 Aug 2023
Historique:
medline:
1
11
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
ppublish
Résumé
SARS-CoV-2 infection, which causes the respiratory disease COVID-19, has spread rapidly from Wuhan, China, since 2019, causing nearly 7 million deaths worldwide in three years. In addition to clinical risk factors such as diabetes, hypertension, and obesity, genetic variability is an important predictor of disease severity and susceptibility. We analyzed common polymorphisms within the LZTFL1 (rs11385942) and ABCA3 (rs13332514) genes in 519 SARS-CoV-2-positive subjects (164 asymptomatic, 246 symptomatic, and 109 hospitalized COVID-19 survivors) and a population-based control group (N?=?2,592; COVID-19 status unknown). Rare ABCA3 AA homozygotes (but not A allele carriers) may be at a significantly increased risk of SARS-CoV-2 infection [P?=?0.003; OR (95 % CI); 3.66 (1.47-9.15)]. We also observed a borderline significant difference in the genotype distribution of the LZTFL1 rs11385942 polymorphism (P?=?0.04) between the population sample and SARS-CoV-2-positive subjects. In agreement with previous studies, a nonsignificantly higher frequency of minor allele carriers was detected among hospitalized COVID-19 subjects. We conclude that a common polymorphism in the ABCA3 gene may be a significant predictor of susceptibility to SARS-CoV-2 infection.
Substances chimiques
LZTFL1 protein, human
0
Transcription Factors
0
ABCA3 protein, human
0
ATP-Binding Cassette Transporters
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
539-543Références
Physiol Res. 2020 Jul 16;69(3):379-388
pubmed: 32469225
Front Med (Lausanne). 2022 Jun 20;9:910098
pubmed: 35795626
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
Virol Sin. 2021 Oct;36(5):1241-1244
pubmed: 34668132
Oncogene. 2016 May 19;35(20):2655-63
pubmed: 26364604
PLoS One. 2022 Apr 21;17(4):e0267397
pubmed: 35446896
Expert Rev Clin Pharmacol. 2021 May;14(5):601-621
pubmed: 33705239
Hum Mol Genet. 2012 Feb 15;21(4):765-75
pubmed: 22068586
Clin Chim Acta. 2021 Aug;519:206-209
pubmed: 33957095
J Med Life. 2021 Jan-Mar;14(1):118-120
pubmed: 33767796
Viruses. 2023 Jan 07;15(1):
pubmed: 36680215
Int J Infect Dis. 2022 Sep;122:427-436
pubmed: 35753602
Clin Chim Acta. 2023 Jan 1;538:211-215
pubmed: 36572138
Physiol Res. 2021 Mar 17;70(1):111-115
pubmed: 33728925
Atherosclerosis. 2010 Aug;211(2):676-81
pubmed: 20471016
Physiol Res. 2021 Dec 16;70(S2):S227-S247
pubmed: 34913354
Physiol Res. 2021 Dec 16;70(S2):S125-S134
pubmed: 34913347
Front Genet. 2020 Aug 31;11:568303
pubmed: 33110422
Adv Clin Chem. 2022;107:41-77
pubmed: 35337605
Biochem Soc Trans. 2015 Oct;43(5):913-9
pubmed: 26517903